103.71M
Market cap
Current P/E
22.88x
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice.

Similar securities

Based on sector and market capitalization

Report issue